儿童肝硬化病因研究进展
Advancements in Etiological Research of Pediatric Liver Cirrhosis
DOI: 10.12677/acm.2026.162358, PDF,   
作者: 张思齐, 许红梅*：重庆医科大学附属儿童医院感染科，儿童少年健康与疾病国家临床医学研究中心，儿童发育疾病研究教育部重点实验室，儿童感染与免疫罕见病重庆市重点实验室，重庆
关键词: 肝硬化；儿童；病因；诊断；Cirrhosis； Children； Etiology； Diagnosis
摘要: 儿童肝硬化(Pediatric Liver Cirrhosis)发病率近年来呈不断上升的趋势，随着科技的进步和环境、遗传等因素的变化，导致儿童肝硬化的原因也变得多样，除了常见的感染性和先天结构性异常之外，越来越多原因不明的儿童肝硬化病例得以明确诊断。儿童肝硬化可对患儿的生长发育、认知功能及心理健康产生长远的不利影响。从广泛的社会角度来看，儿童肝硬化增加了患儿家庭的经济负担与心理压力，同时影响了医疗资源分配。基于此，本文对当前儿童肝硬化病因的研究进展展开系统梳理与总结，旨在为该病症的临床诊断、治疗以及预后评估提供帮助。
Abstract: In recent years, the incidence of pediatric liver cirrhosis has shown a continuous upward trend. With advancements in technology and changes in environmental and genetic factors, the causes of pediatric liver cirrhosis have become increasingly diverse. Besides common infectious and congenital structural abnormalities, a growing number of pediatric liver cirrhosis cases with unknown causes have been clearly diagnosed. Pediatric liver cirrhosis can exert long-term adverse effects on the growth and development, cognitive function, and mental health of affected children. From a broader societal perspective, pediatric liver cirrhosis increases the financial burden and psychological stress on the families of patients while also impacting the allocation of medical resources. Based on this, this article systematically reviews and summarizes the current research progress on the etiology of pediatric liver cirrhosis, aiming to provide assistance in the clinical diagnosis, treatment, and prognosis evaluation of this condition.
文章引用：张思齐, 许红梅. 儿童肝硬化病因研究进展[J]. 临床医学进展, 2026, 16(2): 31-38. https://doi.org/10.12677/acm.2026.162358

参考文献

[1] 单姗, 赵连晖, 马红, 等. 肝硬化的定义、病因及流行病学[J]. 临床肝胆病杂志, 2021, 37(1): 14-16.
[2] Devarbhavi, H., Asrani, S.K., Arab, J.P., Nartey, Y.A., Pose, E. and Kamath, P.S. (2023) Global Burden of Liver Disease: 2023 Update. Journal of Hepatology, 79, 516-537. [Google Scholar] [CrossRef] [PubMed]
[3] Asrani, S.K., Devarbhavi, H., Eaton, J. and Kamath, P.S. (2019) Burden of Liver Diseases in the World. Journal of Hepatology, 70, 151-171. [Google Scholar] [CrossRef] [PubMed]
[4] Enomoto, H., Ueno, Y., Hiasa, Y., Nishikawa, H., Hige, S., Takikawa, Y., et al. (2020) Transition in the Etiology of Liver Cirrhosis in Japan: A Nationwide Survey. Journal of Gastroenterology, 55, 353-362. [Google Scholar] [CrossRef] [PubMed]
[5] Magnius, L., Mason, W.S., Taylor, J., Kann, M., Glebe, D., Dény, P., et al. (2020) ICTV Virus Taxonomy Profile: Hepadnaviridae. Journal of General Virology, 101, 571-572. [Google Scholar] [CrossRef] [PubMed]
[6] Schlaak, J.F. (2023) Current Therapy of Chronic Viral Hepatitis B, C and D. Journal of Personalized Medicine, 13, Article 964. [Google Scholar] [CrossRef] [PubMed]
[7] Rogers, M.E. and Balistreri, W.F. (2021) Cascade of Care for Children and Adolescents with Chronic Hepatitis C. World Journal of Gastroenterology, 27, 1117-1131. [Google Scholar] [CrossRef] [PubMed]
[8] Cobb, B.R. and Valsamakis, A. (2016) Chronic Hepatitis B, C, and D. Microbiology Spectrum, 4, 1-24. [Google Scholar] [CrossRef] [PubMed]
[9] Connolly, S.A., Jardetzky, T.S. and Longnecker, R. (2020) The Structural Basis of Herpesvirus Entry. Nature Reviews Microbiology, 19, 110-121. [Google Scholar] [CrossRef] [PubMed]
[10] Young, L.S., Yap, L.F. and Murray, P.G. (2016) Epstein-Barr Virus: More than 50 Years Old and Still Providing Surprises. Nature Reviews Cancer, 16, 789-802. [Google Scholar] [CrossRef] [PubMed]
[11] Kelgeri, C., Couper, M., Gupte, G.L., Brant, A., Patel, M., Johansen, L., et al. (2022) Clinical Spectrum of Children with Acute Hepatitis of Unknown Cause. New England Journal of Medicine, 387, 611-619. [Google Scholar] [CrossRef] [PubMed]
[12] Martin Mateos, R. and Albillos, A. (2019) Sepsis in Patients with Cirrhosis Awaiting Liver Transplantation: New Trends and Management. Liver Transplantation, 25, 1700-1709. [Google Scholar] [CrossRef] [PubMed]
[13] Strnad, P., Tacke, F., Koch, A. and Trautwein, C. (2017) Liver—Guardian, Modifier and Target of Sepsis. Nature Reviews Gastroenterology & Hepatology, 14, 55-66. [Google Scholar] [CrossRef] [PubMed]
[14] Villanueva, C., Albillos, A., Genescà, J., Garcia-Pagan, J.C., Brujats, A., Calleja, J.L., et al. (2021) Bacterial Infections Adversely Influence the Risk of Decompensation and Survival in Compensated Cirrhosis. Journal of Hepatology, 75, 589-599. [Google Scholar] [CrossRef] [PubMed]
[15] 何兴. 寄生虫感染所致肝纤维化的疾病负担及病理特征[J]. 中国热带医学, 2023, 23(10): 1058-1062+1098.
[16] Olave, M.C., Gurung, A., Mistry, P.K., Kakar, S., Yeh, M., Xu, M., et al. (2020) Etiology of Cirrhosis in the Young. Human Pathology, 96, 96-103. [Google Scholar] [CrossRef] [PubMed]
[17] Hannah, W.B., Derks, T.G.J., Drumm, M.L., Grünert, S.C., Kishnani, P.S. and Vissing, J. (2023) Glycogen Storage Diseases. Nature Reviews Disease Primers, 9, Article No. 46. [Google Scholar] [CrossRef] [PubMed]
[18] Aldámiz-Echevarría, L., de las Heras, J., Couce, M.L., Alcalde, C., Vitoria, I., Bueno, M., et al. (2020) Non-Alcoholic Fatty Liver in Hereditary Fructose Intolerance. Clinical Nutrition, 39, 455-459. [Google Scholar] [CrossRef] [PubMed]
[19] Goyal, N.P., Xanthakos, S. and Schwimmer, J.B. (2025) Metabolic Dysfunction-Associated Steatotic Liver Disease in Children. Gut, 74, 669-677. [Google Scholar] [CrossRef] [PubMed]
[20] Pfrieger, F.W. (2023) The Niemann-Pick Type Diseases—A Synopsis of Inborn Errors in Sphingolipid and Cholesterol Metabolism. Progress in Lipid Research, 90, Article ID: 101225. [Google Scholar] [CrossRef] [PubMed]
[21] Dimitriou, E., Moraitou, M., Cozar, M., Serra-Vinardell, J., Vilageliu, L., Grinberg, D., et al. (2020) Gaucher Disease: Biochemical and Molecular Findings in 141 Patients Diagnosed in Greece. Molecular Genetics and Metabolism Reports, 24, Article ID: 100614. [Google Scholar] [CrossRef] [PubMed]
[22] 谢莉, 蔡稔. 希特林蛋白(Citrin)缺陷病研究进展[J]. 中国优生与遗传杂志, 2018, 26(8): 7-8+48.
[23] 刘文雯, 钟雪梅. 希特林蛋白缺乏症的研究进展[J]. 中国医刊, 2022, 57(9): 957-961.
[24] Lo, C. and Bandmann, O. (2017) Epidemiology and Introduction to the Clinical Presentation of Wilson Disease. Handbook of Clinical Neurology, 142, 7-17.
[25] Socha, P., Janczyk, W., Dhawan, A., Baumann, U., et al. (2018) Wilson’s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition, 66, 334-344. [Google Scholar] [CrossRef] [PubMed]
[26] 纪雷, 张莹, 孔丽, 等. 83例肝豆状核变性患者的临床特征分析[J]. 临床肝胆病杂志, 2022, 38(8): 1843-1846.
[27] European Association for the Study of the Liver (2025) EASL-ERN Clinical Practice Guidelines on Wilson’s Disease. Journal of Hepatology, 82, 690-728. [Google Scholar] [CrossRef] [PubMed]
[28] 邹标, 刘圣烜, 何嘉怡, 等. 36例儿童肝硬化病因及临床特征分析[J]. 中国实用儿科杂志, 2022, 37(7): 516-522.
[29] Antala, S. and Taylor, S.A. (2022) Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes. Clinics in Liver Disease, 26, 341-354. [Google Scholar] [CrossRef] [PubMed]
[30] Plessier, A., Rautou, P.E. and Valla, D.C. (2012) Management of Hepatic Vascular Diseases. Journal of Hepatology, 56, S25-S38. [Google Scholar] [CrossRef] [PubMed]
[31] De Gottardi, A., Rautou, P., Schouten, J., Rubbia-Brandt, L., Leebeek, F., Trebicka, J., et al. (2019) Porto-Sinusoidal Vascular Disease: Proposal and Description of a Novel Entity. The Lancet Gastroenterology & Hepatology, 4, 399-411. [Google Scholar] [CrossRef] [PubMed]
[32] Hernández-Gea, V., Campreciós, G., Betancourt, F., Pérez-Campuzano, V., Seijo, S., Díaz, A., et al. (2021) Co-Expression Gene Network Analysis Reveals Novel Regulatory Pathways Involved in Porto-Sinusoidal Vascular Disease. Journal of Hepatology, 75, 924-934. [Google Scholar] [CrossRef] [PubMed]
[33] 刘亚莉, 王建设, Alastair Baker. 儿童特发性非肝硬化门静脉高压症的诊治进展[J]. 中国中西医结合消化杂志, 2024, 32(12): 1060-1064.
[34] Murata, Y., Abe, M., Furukawa, S., Kumagi, T., Matsui, H., Matsuura, K., et al. (2006) Clinical Features of Symptomatic Primary Biliary Cirrhosis Initially Complicated with Esophageal Varices. Journal of Gastroenterology, 41, 1220-1226. [Google Scholar] [CrossRef] [PubMed]
[35] 王倩凤, 詹丽, 魏小果, 等. 药物性肝炎的临床特征分析[J]. 西部中医药, 2020, 33(4): 90-92.
[36] Kumachev, A. and Wu, P.E. (2021) Drug-Induced Liver Injury. Canadian Medical Association Journal, 193, E310. [Google Scholar] [CrossRef] [PubMed]
[37] 磨奕玲, 周晓玲, 孙东琪, 等. 肝脏缺氧微环境与肝硬化发生发展关系的研究现状[J]. 中西医结合肝病杂志, 2025, 35(9): 1181-1185.
[38] Dickson, I. (2019) Improving Hepatic Ischaemia-Reperfusion Injury Outcomes. Nature Reviews Gastroenterology & Hepatology, 16, 583. [Google Scholar] [CrossRef] [PubMed]
[39] Liu, Z., Lin, C., Mao, X., Guo, C., Suo, C., Zhu, D., et al. (2023) Changing Prevalence of Chronic Hepatitis B Virus Infection in China between 1973 and 2021: A Systematic Literature Review and Meta-Analysis of 3740 Studies and 231 Million People. Gut, 72, 2354-2363. [Google Scholar] [CrossRef] [PubMed]
[40] Yan, R., Sun, M., Yang, H., Du, S., Sun, L. and Mao, Y. (2025) 2024 Latest Report on Hepatitis B Virus Epidemiology in China: Current Status, Changing Trajectory, and Challenges. Hepatobiliary Surgery and Nutrition, 14, 66-77. [Google Scholar] [CrossRef] [PubMed]
[41] 王建设, 刘腾. 儿童肝脏疾病面临的新挑战[J]. 中华儿科杂志, 2025, 63(8): 827-829.

为你推荐